AQP4 appears to be involved in the removal of oedema fluid from the brain in a variety of disorders and enhancing AQP4 expression could be a therapeutic strategy for reducing dilated perivascular spaces and WMH associated with advancing age and Alzheimer’s disease. The gene discussed is AQP4; the disease is early-onset autosomal dominant Alzheimer disease.